Dialysis anemia battle: High-Dose iron vs. standard care
NCT ID NCT06884280
Summary
This study aims to find the best way to manage anemia, a common and debilitating side effect of kidney failure, in people using peritoneal dialysis. It will compare a proactive, high-dose intravenous iron treatment against a standard, lower-dose approach (either IV or pills). Researchers will monitor 30 participants for a year to see which method better improves energy, quality of life, and reduces the need for blood transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hull University Teaching Hospitals NHS Trust
RECRUITINGHull, East Riding Of Yorkshire, HU3 2JZ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.